AMEXConsumer StaplesHousehold & Personal ProductsSnapshot 2026-07-23
Reading ACU? Create a free portfolio, then add this holding for ongoing Reports and tracking. Track it in a free portfolio. No credit card.
Create your account →A long-form read on the 1–3 year hold thesis. Slower and deeper than the daily snapshot — it refreshes only when the evidence moves.
This investment represents a turnaround story with a focus on improving operational efficiency and integrating recent acquisitions. The current thesis state is mixed, reflecting both progress and challenges in profitability and growth.
The market appears to be pricing in a neutral outlook for ACU, with a low expectations gap. Valuation shows a durable premium compared to peers, suggesting that investors may expect stable performance but are cautious about future growth.
Fundamentals are likely to show gradual improvement as management integrates the My Medic acquisition and focuses on cost control. However, recent results indicate some volatility in operating income, which could impact overall profitability in the near term.
The thesis hinges on management's ability to execute on integration and profitability improvements. Additionally, external factors like inflation trends and performance of sector leaders could significantly influence ACU's trajectory.
Over the next 1 to 3 years, ACU's performance will depend on its operational execution and market conditions. Not investment advice.
The most important moves since the prior daily snapshot.
Yes, our read has strengthened. The latest earnings beat and the maintenance of the dividend payout of $0.16 per share support this improved outlook. There are no significant threats noted at this time.
as of 2026-07-23
Specific, dated things to watch for, each with what would confirm it and what would prove it wrong.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Why it matters: Earnings results will show if the company can recover from the recent earnings miss.
Confirms one read:The Q2 earnings report shows revenue growth and a profit.
Confirms the other:Q2 earnings report shows another earnings miss or decline in revenue.
Why it matters: Maintaining the dividend payout shows the company is stable. It also shows they care about shareholders.
Confirms:Management confirms the $0.16 dividend payout in the next earnings report.
Disproves:Management says they will lower the dividend payout.
Why it matters: Changes in gross margins will indicate how well the company manages tariff costs.
Confirms one read:Gross margin improves to above 43% in Q3.
Confirms the other:Gross margin falls below 41% in Q3.
Why it matters: Keeping the $0.16 dividend shows strong capital use. Investors will seek proof of this.
Confirms:The dividend stays at $0.16 per share for the next quarter. This shows commitment to shareholders.
Disproves:A dividend cut or drop below $0.16 shows financial trouble.
Why it matters: Retail sales data can show how much consumers want to buy. This affects Acme United's sales.
Confirms one read:Retail sales increase by more than 1% month over month.
Confirms the other:Retail sales decline by more than 1% month over month.
Why it matters: Better operating income is important for long-term growth. Investors will look for signs of efficiency.
Confirms:Operating income goes up from the last quarter. This shows better efficiency.
Disproves:Operating income is down again. This shows problems in operations continue.
Why it matters: A successful acquisition could help growth and market position. Investors will watch for updates.
Confirms:There is an announcement about a completed acquisition or a key step in the process.
Disproves:No updates or delays in the acquisition process may mean there are problems.
Why it matters: If revenue growth picks up, it could signal a stronger market for Acme United Corp. and improve its outlook.
Confirms:The Consumer Staples sector shows revenue growth speeding up to 6% year over year.
Disproves:Sector revenue growth remains below 4% year over year.
Why it matters: Strong sales growth from My Medic would show that the company is doing well.
Confirms:My Medic sales increase by more than 20% in Q3 compared to Q2.
Disproves:My Medic sales growth is less than 10% in Q3 compared to Q2.
Why it matters: Higher operating income means the company is managing costs well. This helps them make more money.
Confirms:Operating income increases by more than 10% in Q3 compared to Q2.
Disproves:Operating income declines or stays flat in Q3 compared to Q2.
